Abstract

The aim of this study was to evaluate acyclic ligands which can be applied for labeling proteins such as monoclonal antibodies and their fragments with scandium radionuclides. Recently, scandium isotopes (47Sc, 44Sc) are more available and their properties are convenient for radiotherapy or PET imaging. They can be used together as “matched pair” in theranostic approach. Because proteins denaturize at temperature above 42 °C, ligands which efficiently form complexes at room temperature, are necessary for labelling such biomolecules. For complexation of scandium radionuclides open chain ligands DTPA, HBED, BAPTA, EGTA, TTHA and deferoxamine have been chosen. We found that the ligands studied (except HBED) form strong complexes within 10 min and that the radiolabelling yield varies between 96 and 99 %. The complexes were stable in isotonic NaCl, but stability of 46Sc-TTHA, 46Sc-BAPTA and 46Sc-HBED in PBS buffer was low, due to formation by Sc3+stronger complexes with phosphates than with the studied ligands. From the radiolabelling studies with n.c.a. 47Sc we can conclude that the most stable complexes are formed by the 8-dentate DTPA and EGTA ligands.

Highlights

  • The aim of this study was to evaluate acyclic ligands which can be applied for labeling proteins such as monoclonal antibodies and their fragments with scandium radionuclides

  • We found that the ligands studied form strong complexes within 10 min and that the radiolabelling yield varies between 96 and 99 %

  • The complexes were stable in isotonic NaCl, but stability of 46Sc-TTHA, 46ScBAPTA and 46Sc-HBED in PBS buffer was low, due to formation by Sc3?stronger complexes with phosphates than with the studied ligands

Read more

Summary

Introduction

The aim of this study was to evaluate acyclic ligands which can be applied for labeling proteins such as monoclonal antibodies and their fragments with scandium radionuclides. From the radiolabelling studies with n.c.a. 47Sc we can conclude that the most stable complexes are formed by the 8-dentate DTPA and EGTA ligands. This radionuclide can be produced in nuclear reactors by n,c reaction and is commercially available at high levels of specific activity and chemical purity. Some amount of stable 176Lu cannot be avoided, which may cause some problems concerning receptor saturation with biomolecules labelled with stable isotope, especially when the number of receptors is limited For this purpose an alternative production route via neutron capture, starting with enriched 176Yb targets, has been demonstrated [2,3,4].

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call